The largest database of trusted experimental protocols

Cd4 dynabeads

Manufactured by Thermo Fisher Scientific
Sourced in Norway

Thermo Fisher Scientific's CD4 Dynabeads are magnetic beads coated with antibodies specific to the CD4 surface marker. They are designed for the isolation and enrichment of CD4+ T cells from various sample types, such as whole blood or cell suspensions. The beads can be used in combination with appropriate cell separation and downstream analysis techniques.

Automatically generated - may contain errors

14 protocols using cd4 dynabeads

1

Detecting IFN-γ-producing CD8 T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to detect only IFN-γ-producing CD8 T cells, ELISPOT assays were carried out with PBMCs or lymph node mononuclear cells (LNMC) after negative selection of CD4 T-lymphocyte populations fractionated by magnetic bead separation (CD4 Dynabeads; Dynal, Oslo, Norway) as previously described [20 (link)]. Negatively selected CD4 T cells were >90% CD8 T cells. CD4 T cell-depleted PBMC and LNMC were suspended in R-10 medium and used the same day in ELISPOT assays. Isolated lymph node CD4 T cells were pelleted and used for RNA extraction and cell-associated viral RNA quantitation and sequencing.
+ Open protocol
+ Expand
2

Activation and Expansion of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD3 antibody (eBioscience, cat.no. 16-0037-85) was diluted 1:200 in sterile PBS and used to coat T75 flasks or wells in 12- or 24-well plates for 1 h at 37 °C. The antibody solution was then removed and the flasks or wells were washed three times with sterile 1× PBS. PBMCs were diluted in the growth medium to 10 to 20 × 106 cells/flask with 20 mL of the final volume or at a cell density of 2 × 105 to 1 × 106 cells/mL in 12- or 24-well plates. CD28 antibody (eBioscience, cat.no. 16-0289-85) at a concentration of 1 µg/mL was added to the flask or wells. The flasks or wells were further incubated for 3 days before running experiments. This protocol was also used in the experiments with pure CD4+ T cells (>99%) isolated from PBMC with CD4 Dynabeads® in combination with Detachabead®reagent (Dynal, Oslo, Norway). For comparison, cells were also activated overnight with PHA (5 µg/mL) or cell stimulation cocktail (CSC, 1×), a mixture of phorbol 12-myristate 13-acetate (PMA) and ionomycin (eBioscience, cat.no. 00-4970-93). In some experiments, expansion of a T-cell population was stimulated by using recombinant IL-2 [33 (link)]. After coating flasks/wells with anti-CD3 antibody, recombinant IL-2-human (10 U/mL) (Sigma-Aldrich, cat.no. 57600-1VL) was used to activate the T cells. The flasks or wells were further incubated for 3 days before experiments.
+ Open protocol
+ Expand
3

Isolation and Enrichment of Mouse T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells from donor mice were isolated from LNs and spleen by passing tissue through a 40-μm filter to obtain single cell suspension. This cell suspension was treated with ACK lysis buffer to deplete red blood cells (RBCs). OT-I x CCR5+/+ mice are on a Rag2−/− background, and T cells isolated from these mice were 75–80% CD8+ without additional enrichment steps. CD8+ T cells from OT-I x CCR5−/− and C57BL/6 mice were enriched using negative selection with B220 and CD4 Dynabeads (Life Technologies, Grand Island, NY). OT-II T cells were enriched using negative selection with B220 and CD8 Dynabeads.
+ Open protocol
+ Expand
4

CFSE-based T cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CFSE dilution assays, splenic and LN CD4+ OT‐II T cells were purified using CD4+ Dynabeads (Life Technologies) following the manufacturer's protocol. T cells were labeled with 5 μM CFSE (Life Technologies) for 15 min at 37°C, prior to culture with 5 × 104 WT or Ifnar1−/− FLDCs in the presence of 0.01 μg/ml OVA323–339 peptide (CRB) or 5 μg/ml OVA protein (Sigma) which had been endotoxin depleted in‐house. Cultures were incubated at 37°C for 4 days prior to assessment of CFSE dilution by flow cytometry. In vitro co‐culture polarization experiments were performed with 5 × 104 KN2xIL‐13eGFP− CD4+ or KN2xIL‐10eGFP− CD4+ T cells which were cultured in 96‐well plates for 4 days with 2,500 WT or Ifnar1−/− FLDCs, 1 μg/ml soluble anti‐CD3, and with or without rIL‐4 (20 ng/ml; PeproTech; Cook et al, 2015). T cell expression of huCD2 (IL‐4; Life Technologies) or eGFP (IL‐10 or IL‐13) was then assessed by flow cytometry.
+ Open protocol
+ Expand
5

Isolation and Transfer of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD25+ T reg cells (>90% pure) were isolated from spleens and LNs of CD45.1+ WT, CD45.2+Ifnar1−/−, or Ifnar1−/−Cd28−/− mice by magnetic separation using CD4 Dynabeads (Invitrogen) and CD25 microbeads (Miltenyi Biotech). 5–10 × 105 CD4+CD25+ T reg cells were injected intravenously into each recipient CD45.1+CD45.2+ mouse. For transfer of CD44hi T reg cells, Foxp3GFP mice were pretreated with IL-2 complex before T reg cell isolation: 50 µg anti–IL-2 (JES6; BioXCell) was incubated with 1.5 µg recombinant murine IL-2 (carrier free; eBioscience) in PBS overnight at 4°C and injected into donor mice intraperitoneally on days 0, 2, and 4. Mice were sacrificed on day 6 for sorting of CD4+Foxp3GFPCD44hiCD62Llo T reg cells. 5 × 105 sorted T reg cells were transferred per mouse. Mice were infected 1 d after transfer. For IL-2, ICOSL, and B7-1/B7-2 blockade, recipient mice were injected intraperitoneally with a mixture of 100 µg anti–IL-2 (JES6; BioXCell) and 100 µg anti-IL-2 (S4B61; BioXCell), with 100 µg anti-ICOSL (HK5.3; BioXCell), with a mixture of 100 µg anti–B7-1 (16-10A1; BioXCell) and 100 µg anti–B7-1 (GL-1; BioXCell), or with 100 µg rat IgG (Sigma-Aldrich) before T reg cell transfer (day −1) and every 2 d thereafter.
+ Open protocol
+ Expand
6

Regulatory T Cell-Mediated Modulation of Islet Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human islets were dissociated into single cells with 0.05% trypsin-EDTA. The single cells (0.5 million cells) were cultured with or without 1 million ex vivo expanded Tregs in the presence of CD3/CD28 beads in 10% HS RPMI-1640 medium for 48 hours. LPS (1 µg/mL) was then added to the cultures for an additional 24 hours. As a control, the islets were co-cultured with autologous Teffs under the same conditions. After the incubation period, Tregs or Teffs were positively isolated using CD4 Dynabeads (Invitrogen). The eluted fraction was used for flow cytometric analysis and real-time RT-PCR for expression of MCP-1.
+ Open protocol
+ Expand
7

Splenic Cell Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic cells (2.4 × 105) were stimulated with Pokeweed mitogen (PWM, 40 μg/ml, Sigma, St Louis, MO), human IL-2 (15 U/ml), IL-4 (100 U/ml) (Life Technologies), and human CD3 and CD28 Abs (1 μg/ml each, BD Biosciences). At day 7 of culture, half of the medium was replaced by fresh medium. Immunoglobulin secretion in supernatants at day 16 of culture was measured by an enzyme-linked immunosorbent assay (ELISA) (human IgG ELISA quantitation set; Bethyl Laboratories,). For co-cultures, negatively isolated human CD4 T cells (7.5 × 104) from DRAG mice (CD4 dynabeads, Invitrogen) were added to the splenic cells of A2 mice and stimulated as above.
+ Open protocol
+ Expand
8

Isolation and Activation of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were isolated and stimulated as previously described10 (link). Briefly, CD4+ T cells were isolated from whole blood by negative selection using RosetteSep human CD4+ T cell enrichment cocktail (STEMCELL Technologies Inc., Vancouver, BC) and RosetteSep density medium gradient centrifugation. Isolated CD4+ T cells were placed in freezing container at −80°C for overnight, and then moved into a liquid nitrogen tank for long-term storage. On the day of activation, CD4+ T cells were thawed in a 37°C water bath, counted and resuspended in RPMI-1640 supplemented with 10% FCS, and plated at 50,000 cells per well in a 96 well round-bottom plate. Cells were either left untreated or stimulated with beads conjugated with anti-CD3 and anti-CD28 antibodies (Dynabeads, Invitrogen #11131D, Life Technologies) at a cell:bead ratio of 1:1 for 48 hours, a time point we previously found to maximize the gene expression response in CD4+ T cells. At each time point, cells were further purified by a second step positive selection with CD4+ Dynabeads (Invitrogen #11145D, Life Technologies).
+ Open protocol
+ Expand
9

CFSE-Based T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CD4+ T cells (CD4 T cells beads, Miltenyi or CD4 Dyna Beads, Invitrogen) were labeled with CFSE or CellTrace Volet (CTV) (Thermofisher) according to manufacturer’s protocol and cultured in RPMI 1640 complete medium supplemented with 10% fetal bovine serum (FBS, GIBCO Sigma), 100 U/mL penicillin, 100 μg/mL streptomycin and 2 mM L-glutamine (all from GIBCO) together with DC and irradiated feeder cells (40 Gy) in 2:1:1 ratio for 72 or 96h. Polyclonal CD4+ T cells were stimulated with αCD3 (2C11) and αCD28 (37.51) (BioXcell); OT-II cells with OVA323-339 (ISQAVHAAHAEINEAGR) peptide (Pepscan) and Trp1 cells with Trp1106-130 (SGHNCGTCRPGWRGAACNQKILTVR) peptide (Pepscan) at concentration indicated in the Figure 2. Cells were additionally supplemented with IL-2, IL-15 or IL-7 (Peprotech) at a concentration indicated in the Figure 2. Mouse CD4+ T cells were cultured with αCD25 (PC61, BioXcell) and αIL-2 (JES6-1A12, BioXcell), added to the culture 24h post stimulation with αCD3 and αCD28 in a concentration of 5 μg/ml.
+ Open protocol
+ Expand
10

Tracking T cell responses in vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells from CD45.1+2+ TSLPR-WT or CD45.2+ TSLPR-KO donors, both expressing the 4C13R double reporter, were enriched by positive selection, using either CD4 Dynabeads (Invitrogen) or CD4 microbeads with an autoMACS Pro Separator (Miltenyi Biotec), and injected i.v. into OTII mice back-crossed onto a CD45.1+ background. OTII-recipient mice were used as their response to MC903 is reduced compared with C57BL/6 mice, thus allowing a more sensitive detection of transferred T cells. Similar results but lower donor cell recoveries were obtained using B6-SJ recipients. MC903 treatment was started 1 d after T cell transfer, and mice were killed on day 8.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!